The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
This depends on the severity of your deficiency, but many people start with a short loading course followed by maintenance injections every few months
doi:10.1210/endo.142.12.8522 Heffernan MA, Thorburn AW, Fam B, et al
It is natively an orally-active compound
Understanding vitamin B12 therapy well helps us make patients lives better
Indeed, after a decade or so, those who had been taking high-dose B6 supplements had about a 40 percent higher hip fracture risk, but not those taking B12